Clinical Trials Logo
  1. Home
  2. Von Willebrand Diseases
  3. NCT04887324

Real-life Data of Constitutional Von Willebrand Disease in Western France — HOPSCOTCH-II  

Von Willebrand Diseases Clinical Trial

Official title:
Real-life Data of Constitutional Von Willebrand Disease in Western France: Treatment Outcomes With the Recombinant Von Willebrand Factor

Clinical Trial Summary

The objective of this observational study HOPSCOTcH-WILL II is to provide an accurate and detailed account of current Von Willebrand Disease (VWD) therapeutic management by collecting real-life data on hemorrhagic treated events in the 5 Western French Hemophilia Treatment Center. The HOPSCOTCH-WILL II study aims to describe therapeutic management of patients with VWD, following the provision of a recombinant drug in France; It will also permit to carry out a budget impact analysis to quantify the economic significance of this new era.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04887324
Study type Observational
Source Nantes University Hospital
Contact Marc Trossaert
Phone 0240087468
Email marc.trossaert@chu-nantes.fr
Status Recruiting
Phase
Start date July 7, 2023
Completion date July 30, 2024
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04398628 - ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Completed NCT03621020 - Clinical Performance Evaluation of T-TAS 01 PL Chip
Recruiting NCT04146376 - Von Willebrand Factor in Pregnancy (VIP) Study
Recruiting NCT03715673 - Von Willebrand Antigen and Activity as Novel Biomarkers of Hemostasis in Inflammatory Bowel Disease
Completed NCT03875924 - REAL-LIFE DATA OF CONSTITUTIONAL VON WILLEBRAND DISEASE IN WESTERN FRANCE (HOPSCOTcH-WILL)
Recruiting NCT03773159 - Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions
Recruiting NCT04119908 - Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases N/A
Not yet recruiting NCT04106323 - A Study of Factor Inhibitors in Adult Patients With Hemophilia and Von Willebrand's Disease in Upper Egypt
Active, not recruiting NCT03853486 - ATHN 9: Severe VWD Natural History Study
Recruiting NCT05776069 - Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease Phase 1
Recruiting NCT04344860 - Prevent Postpartum Hemorrhage in Women With Von Willebrand Disease: The VWD-WOMAN Trial Phase 3
Completed NCT04053699 - Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment
Not yet recruiting NCT06205095 - A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients With VWD Phase 3
Completed NCT04052698 - Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWD Phase 3
Not yet recruiting NCT05916469 - Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
Completed NCT03078595 - Gingival Bleeding and Von Willebrand Disease Typ 2 and 3
Recruiting NCT03327779 - World Bleeding Disorders Registry
Recruiting NCT03070912 - Frequency of Hemorrhages Associated With the Functional Anomalies of Willebrand Factor in Emergency Patients
Completed NCT04466878 - Prognostic Value of Implementing VCE on Top in Constitutional VWD-patients With GI-bleeding
Recruiting NCT04810702 - Impact of Von Willebrand Factor and Its Multimers on Angiogenesis